Newest
-
Global Times: Chinese technology enhances Kenya’s geothermal efficiency, delivers reliable, clean and affordable power to households
-
Global Times: China’s aircraft carriers make confident strides toward blue waters, play pivotal role in national defense
-
Global Times: 2024 Yearender: China’s space sector soars to new heights, setting new goals
-
Global Times: Chinese photovoltaic tech illuminates Cuban homes, offices, and factories after decades of energy shortages
News
-
Pollo AI Launches Video-to-Video Feature, Revolutionizing Creative AI Video Creation and Outshining Competitors
SINGAPORE and NEW YORK,Dec. 20,2024-- Pollo AI,a leading AI video generator released by HIX.AI,announced the launch of an innovative video-to-video feature today. It allows users to effortlessly tran
12-20
Details -
AUM of USD 635 Billion at ADFW Caps Stellar Q4 as Trillion-Dollar Club Flock to ADGM
ABU DHABI,UAE,Dec. 20,2024-- ADGM,the leading international financial centre of Abu Dhabi and a globally recognised hub for asset and wealth management unveiled nineteen major announcements from glob
12-20
Details -
TMA Automotive Software Center Launched Solutions For Software-Defined Vehicles
HO CHI MINH CITY,Vietnam,Dec. 20,2024-- After several years of intensive investment on R&D,TMA Automotive Software Center has completed a set of new solutions to support development of Software-De
12-20
Details -
DEMATIC STRENGTHENS PRESENCE IN TAIWAN WITH NEW OFFICE OPENING IN TAOYUAN CITY
TAOYUAN,Dec. 18,2024--Dematic,a leading automated solution provider globally and in Asia Pacific,has announced the opening of its new office in Taiwan. This strategic expansion further solidifies Dema
12-19
Details -
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
In a head-to-head diet-induced obese (DIO) mouse study,ASC47 low dose combination 1 (ASC47,3 mg/kg,subcutaneous (SQ),once every four weeks plus semaglutide,30 nmol/kg,SQ,once daily),demonstrated super
12-19
Details -
Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production
SHANGHAI,Dec. 18,2024-- ShanghaiJuncell Therapeutics Co.,Ltd. (Juncell Therapeutics),a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies,annou
12-19
Details -
China's First Factory-Based Seawater Hydrogen Production Project Completed at Sinopec Qingdao Refinery
QINGDAO,China,Dec. 19,2024-- China Petroleum & Chemical Corporation\'s (HKG: 0386,"Sinopec") completes China\'s first factory-based seawater hydrogen production research project at its
12-19
Details -
Gogoro Earns Frost & Sullivan's 2024 Global Company of the Year Award for Pioneering Sustainable Urban Mobility with Groundbreaking Battery-swapping Platform and Ecosystem
Gogoro\'s battery-swapping ecosystem revolutionized urban mobility by offering a sustainable,highly efficient,and customer-centric alternative to traditional electric vehicle charging.
12-19
Details -
Green Power as a Medium to Create a Zero-Carbon Tourism Model
BOLE,China,Dec. 18,2024--On December 17,the temperature atSayram Lake dropped sharply,causing ice waves to form along the edge of the water. Irregularly sized and shaped floating ice blocks collided w
12-19
Details -
Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical
Highlights Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis
12-19
Details